(Q52882768)

9 May 2018

title

Paraoxonase and Arylesterase Levels in Behcet's Disease and Their Relations with the Disease Activity. (English)

1 reference

9 May 2018

0 references

Ayhan Kul

1

0 references

Nurinnisa Öztürk

series ordinal

3

object named as

Nurinnisa Ozturk

1 reference

9 May 2018

author name string

Hulya Uzkeser

series ordinal

2

1 reference

9 May 2018

publication date

7 April 2017

1 reference

9 May 2018

published in

Biochemical Genetics

1 reference

9 May 2018

volume

55

1 reference

9 May 2018

issue

4

1 reference

9 May 2018

page(s)

335-344

1 reference

9 May 2018

https://scigraph.springernature.com/pub.10.1007/s10528-017-9800-2

exact match

0 references

cites work

Behçet's disease: evaluation of a new instrument to measure clinical activity.

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

Serum paraoxonase 1 (PON1) measurement: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

Paraoxonase and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

Serum paraoxonase/arylesterase activity and oxidative stress status in children with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

Serum paraoxonase activity is decreased in the active stage of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

Effects of vitamin E supplementation on blood antioxidants levels in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

Lipid peroxidation and erythrocyte antioxidant enzymes in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

The multiple faces of Behçet's disease and its aetiological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

Trace elements and antioxidant enzymes in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

Lipid Peroxidation and Antioxidant Defence System in Patients with Active or Inactive Behçet's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

The human paraoxonase gene cluster as a target in the treatment of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

Biomarkers of oxidative stress: an analytical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

Antioxidants in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10528-017-9800-2

10.1007/S10528-017-9800-2

21 January 2018

Identifiers

DOI

1 reference

9 May 2018

PubMed ID

28389737

1 reference

9 May 2018